Improving Outcomes through a Neonatal Abstinence Syndrome Collaborative in Maryland.

OBJECTIVES A statewide Maryland Perinatal Neonatal Quality Collaborative, facilitated by the Maryland Patient Safety Center (MPSC), identified the three specific, measurable, attainable, relevant, and time-limited (SMART) aims to improve outcomes of NAS care: (1) to reduce hospital length of stay (LOS), (2) to reduce interhospital transfers, and (3) to reduce 30-day readmission rates of infants with neonatal abstinence syndrome (NAS). STUDY DESIGN The Maryland collaborative developed a bundle of best practices for care of infants with NAS. MPSC partnered with Vermont Oxford Network (VON) to utilize the VON NAS toolkit and provide its standardized NAS educational curriculum to address the three objectives for participating birthing hospitals. Efforts began in quarter 4 (Q4) 2016 and continued for two years. Thirty-one of Maryland's 32 delivery hospitals (97%) participated in the two-year collaborative. Additionally, one specialty pediatric hospital with a NAS unit participated in the group learnings. Participating facilities implemented components of the MPSC NAS bundle and provided their staff caring for infants with NAS and their mothers access to the VON standardized educational curriculum. MPSC partnered with VON to conduct two audits of implementation of policies and procedures in Q1 2016 and Q3 2018. The Maryland Department of Health supplied quarterly aggregate hospital information on LOS, interhospital transfers, and 30-day readmissions of infants with a discharge diagnosis of ICD-10 P96.1. RESULTS Among term infants with NAS with total hospital stay greater than 5 days, we observed a non-significant reduction in both mean and median LOS of 1.5 days. In this same group, the rate of interhospital transfers fell significantly from 20.1% in 2016 to 13.8% in 2017 and to 11.0% in 2018. CONCLUSION The best practice bundle created by the Maryland collaborative was associated with a reduction in the percentage of infants with NAS who required interhospital transfer, thereby reducing family disruption.

[1]  C. Grindeland,et al.  Neonatal Abstinence Syndrome Practices in the United States. , 2021, The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG.

[2]  P. Owens,et al.  Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010–2017 , 2021, Obstetrical and Gynecological Survey.

[3]  P. Melvin,et al.  A quality improvement initiative to implement the eat, sleep, console neonatal opioid withdrawal syndrome care tool in Massachusetts’ PNQIN collaborative , 2020, Journal of Perinatology.

[4]  G. Kenney,et al.  Neonatal abstinence syndrome management in California birth hospitals: results of a statewide survey , 2020, Journal of Perinatology.

[5]  M. Walsh,et al.  Ohio Perinatal Quality Collaborative Improves Care of Neonatal Narcotic Abstinence Syndrome , 2018, Pediatrics.

[6]  E. Shapiro,et al.  An Initiative to Improve the Quality of Care of Infants With Neonatal Abstinence Syndrome , 2017, Pediatrics.

[7]  Jean Y. Ko,et al.  Incidence of Neonatal Abstinence Syndrome - 28 States, 1999-2013. , 2016, MMWR. Morbidity and mortality weekly report.

[8]  A. Holmes,et al.  Rooming-In to Treat Neonatal Abstinence Syndrome: Improved Family-Centered Care at Lower Cost , 2016, Pediatrics.

[9]  J. Horbar,et al.  Improving Care for Neonatal Abstinence Syndrome , 2016, Pediatrics.

[10]  J. Mrozek,et al.  Neonatal drug withdrawal. , 2013, Minnesota medicine.

[11]  J. McAllister,et al.  Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. , 2012, JAMA.

[12]  K. Yaffe,et al.  The Committee on Drugs. , 1978, Maryland state medical journal.

[13]  Dionne A. Graham,et al.  Hospital Variation in Neonatal Abstinence Syndrome Incidence, Treatment Modalities, Resource Use, and Costs Across Pediatric Hospitals in the United States, 2013 to 2016. , 2018, Hospital pediatrics.